Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming.

MLA

Jin, Jinmei, et al. “Cardamonin Inhibits Breast Cancer Growth by Repressing HIF-1α-Dependent Metabolic Reprogramming.” Journal of Experimental & Clinical Cancer Research : CR, vol. 38, no. 1, Aug. 2019, p. 377. EBSCOhost, https://doi.org/10.1186/s13046-019-1351-4.

APA

Jin, J., Qiu, S., Wang, P., Liang, X., Huang, F., Wu, H., Zhang, B., Zhang, W., Tian, X., Xu, R., Shi, H., & Wu, X. (2019). Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming. Journal of Experimental & Clinical Cancer Research : CR, 38(1), 377. https://doi.org/10.1186/s13046-019-1351-4

Chicago

Jin, Jinmei, Shuiping Qiu, Ping Wang, Xiaohui Liang, Fei Huang, Hui Wu, Beibei Zhang, et al. 2019. “Cardamonin Inhibits Breast Cancer Growth by Repressing HIF-1α-Dependent Metabolic Reprogramming.” Journal of Experimental & Clinical Cancer Research : CR 38 (1): 377. doi:10.1186/s13046-019-1351-4.